Results 91 to 100 of about 1,155 (183)

Hidden cracks from the largest earthquake of Türkiye: secondary traumatic stress among psychosocial support teams. [PDF]

Eur J Psychotraumatol
Sisman E, Cerit C, Polat A, Polat A.
europepmc   +1 more source

Terremoto

Revista de las Fuerzas Armadas, 1999
openaire   +1 more source

COVID-19 hardship and mental health in Chilean parents: the role of disaster exposure and family resilience. [PDF]

Eur J Psychotraumatol
Espinoza C, Alink L, Laplante DP, Elzinga B, van der Veek S.   +4 more
europepmc   +1 more source

Characteristics associated with clinical response to pomalidomide in hereditary hemorrhagic telangiectasia. [PDF]

Blood Adv
Al-Samkari H, Thomas SM, Marsh D, Kasthuri RS, Iyer VN, Pishko AM, Decker JE, Weiss CR, Whitehead KJ, Conrad MB, Zumberg MS, Zhou JY, Parambil J, Carper B, Clancy M, McCrae KR.   +15 more
europepmc   +1 more source

Baseline PARP-1 PET imaging in patients with advanced solid tumors with DNA damage response mutations. [PDF]

Eur J Nucl Med Mol Imaging
Daoud T, Chen J, Wei P, Wong F, Yap TA, Lin LL.   +5 more
europepmc   +1 more source

[Tribute to the Unidad de Investigación Médica en Nutrición]. [PDF]

Rev Med Inst Mex Seguro Soc
Rodríguez-Cruz M.
europepmc   +1 more source

Public representations of the nursing image in YouTube comments: analysis based on Jean Watson's theory. [PDF]

Rev Esc Enferm USP
Álvarez-Muñoz E, Malhue-Torres F, Sepúlveda-Rivas C, Zúñiga-Tapia R.   +3 more
europepmc   +1 more source

Assessing the Activation of Tyrosine Kinase KIT through Free Energy Calculations. [PDF]

J Chem Theory Comput, 2022
Sandoval-Pérez A, Winger BA, Jacobson MP.   +2 more
europepmc   +1 more source

Concordance analysis of DNA and RNA profiling: The MD Anderson IMPACT2 study in precision oncology. [PDF]

Signal Transduct Target Ther
Schmidt ST, Baysal MA, Fu S, Hong DS, Piha-Paul SA, Naing A, Rodon Ahnert J, Yap TA, Dumbrava EE, Beck J, Meric-Bernstam F, Tsimberidou AM.   +11 more
europepmc   +1 more source

Exceptional response to the ATR inhibitor, camonsertib, in a patient with ALT+ metastatic melanoma. [PDF]

NPJ Precis Oncol
Ngoi NYL, Silverman IM, Johnson A, Meng C, Schonhoft JD, Zimmermann M, Ulanet D, Kim H, Torrado C, Salguero C, Brown CV, Rodon J, Rimkunas V, Koehler M, Yap TA.   +14 more
europepmc   +1 more source